Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Merck & Co. 16.286, BioNTech 0.114.
Merck & Co. vs BioNTech Net Worth and Market Cap
Merck & Co. (MRK) and BioNTech (BNTX) are peers in Vaccines. Merck & Co. reported revenue of $16.3B as of Q1 2026, compared with $114M for BioNTech. Merck & Co. leads on revenue.
Merck & Co.'s gross margin is 81.9% versus 8.1% for BioNTech. Merck & Co.'s net margin is -26.0% versus -777.3% for BioNTech.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Merck & Co., BioNTech.| Metric | Merck & Co. | BioNTech |
|---|---|---|
| Market Cap | - | - |
| Revenue | $16.29B | $114.00M |
| Cost of Revenue | $2.94B | $105.00M |
| Gross Profit | $13.34B | $9.00M |
| Operating Income | $-1.88B | $-1.02B |
| Net Income | $-4.24B | $-886.00M |
| R&D Expense | $12.56B | $595.00M |
| Earnings Per Share | -$1.72 | -$3.5 |
| Gross Margin | 81.9% | 8.1% |
| Operating Margin | -11.6% | -897.8% |
| Net Profit Margin | -26.0% | -777.3% |
| Free Cash Flow | $2.93B | $-48.00M |
| Cumulative Free Cash Flow | $245.22B | $19.56B |
| Operating Cash Flow | $3.92B | $12.00M |
| Cash & Equivalents | $5.33B | $10.52B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.